AI-enabled bacteriophage medicines as antibiotic alternative. Holds first EU authorisation to market personalised veterinary phage treatments. Expanding into human health.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

About

AI-enabled bacteriophage medicines as antibiotic alternative. Holds first EU authorisation to market personalised veterinary phage treatments. Expanding into human health.

Infectious Disease